248 related articles for article (PubMed ID: 28592786)
1. Epstein-Barr Virus-Associated Lymphoproliferative Disorders: Review and Update on 2016 WHO Classification.
Kim HJ; Ko YH; Kim JE; Lee SS; Lee H; Park G; Paik JH; Cha HJ; Choi YD; Han JH; Huh J;
J Pathol Transl Med; 2017 Jul; 51(4):352-358. PubMed ID: 28592786
[TBL] [Abstract][Full Text] [Related]
2. EBV-associated lymphoproliferative disorders: classification and treatment.
Carbone A; Gloghini A; Dotti G
Oncologist; 2008 May; 13(5):577-85. PubMed ID: 18515742
[TBL] [Abstract][Full Text] [Related]
3. In situ hybridisation for Epstein-Barr virus as a differential diagnostic tool for T- and natural killer/T-cell lymphomas in non-immunocompromised patients.
Chuang SS
Pathology; 2014 Dec; 46(7):581-91. PubMed ID: 25393247
[TBL] [Abstract][Full Text] [Related]
4. Immunodeficiency-Associated Epstein-Barr Virus-Positive B-cell Lymphoproliferative Disorders: A Review and New Paradigm.
Chapman J
Surg Pathol Clin; 2023 Jun; 16(2):213-231. PubMed ID: 37149357
[TBL] [Abstract][Full Text] [Related]
5. Determination of Epstein-Barr Virus-Infected Lymphocyte Cell Types in Peripheral Blood Mononuclear Cells as a Valuable Diagnostic Tool in Hematological Diseases.
Zhang P; Zeng C; Cheng J; Zhou J; Gu J; Mao X; Zhang W; Cao Y; Luo H; Xu B; Li Q; Xiao M; Zhou J
Open Forum Infect Dis; 2019 May; 6(5):ofz171. PubMed ID: 31065564
[TBL] [Abstract][Full Text] [Related]
6. Advances in Understanding the Pathogenesis of Epstein-Barr Virus-Associated Lymphoproliferative Disorders.
Yang X; Nishida N; Zhao X; Kanegane H
Iran J Allergy Asthma Immunol; 2015 Oct; 14(5):462-71. PubMed ID: 26742434
[TBL] [Abstract][Full Text] [Related]
7. [Epstein-Barr virus infection and lymphoproliferative disorders].
Isobe Y
Rinsho Ketsueki; 2020; 61(9):1286-1296. PubMed ID: 33162528
[TBL] [Abstract][Full Text] [Related]
8. [Diagnosis and management of EBV-positive lymphoproliferative disorders].
Arai A
Rinsho Ketsueki; 2023; 64(8):764-771. PubMed ID: 37673629
[TBL] [Abstract][Full Text] [Related]
9. Immunodeficiency-associated lymphoproliferative disorders: time for reappraisal?
Natkunam Y; Gratzinger D; Chadburn A; Goodlad JR; Chan JKC; Said J; Jaffe ES; de Jong D
Blood; 2018 Nov; 132(18):1871-1878. PubMed ID: 30082493
[TBL] [Abstract][Full Text] [Related]
10. Case Report: Composite Angioimmunoblastic T-Cell Lymphoma and Epstein-Barr Virus-Positive B-Cell Lymphoproliferative Disorder as Other Iatrogenic Immunodeficiency-Associated Lymphoproliferative Disorders.
Kakiuchi S; Yakushijin K; Takagi I; Rikitake J; Akiyama H; Matsuba H; Hayashi Y; Kajimoto K; Iwata N
Front Med (Lausanne); 2020; 7():625442. PubMed ID: 33425968
[TBL] [Abstract][Full Text] [Related]
11. Systemic Epstein-Barr Virus-Positive T/NK Lymphoproliferative Diseases With
Ishimura M; Eguchi K; Shiraishi A; Sonoda M; Azuma Y; Yamamoto H; Imadome KI; Ohga S
Front Pediatr; 2019; 7():183. PubMed ID: 31231620
[TBL] [Abstract][Full Text] [Related]
12. Epstein-Barr virus-associated T- and NK-cell lymphoproliferative diseases: an update and diagnostic approach.
Hue SS; Oon ML; Wang S; Tan SY; Ng SB
Pathology; 2020 Jan; 52(1):111-127. PubMed ID: 31767131
[TBL] [Abstract][Full Text] [Related]
13. Senile Epstein-Barr virus-associated B-cell lymphoproliferative disorders: a mini review.
Shimoyama Y; Oyama T; Asano N; Oshiro A; Suzuki R; Kagami Y; Morishima Y; Nakamura S
J Clin Exp Hematop; 2006 Mar; 46(1):1-4. PubMed ID: 17058802
[TBL] [Abstract][Full Text] [Related]
14. Treatment Advances in EBV Related Lymphoproliferative Diseases.
Lv K; Yin T; Yu M; Chen Z; Zhou Y; Li F
Front Oncol; 2022; 12():838817. PubMed ID: 35515118
[TBL] [Abstract][Full Text] [Related]
15. Epstein-Barr Virus-Associated T and NK-Cell Lymphoproliferative Diseases.
Kim WY; Montes-Mojarro IA; Fend F; Quintanilla-Martinez L
Front Pediatr; 2019; 7():71. PubMed ID: 30931288
[TBL] [Abstract][Full Text] [Related]
16. Malignancies associated with epstein-barr virus: pathobiology, clinical features, and evolving treatments.
Neparidze N; Lacy J
Clin Adv Hematol Oncol; 2014 Jun; 12(6):358-71. PubMed ID: 25003566
[TBL] [Abstract][Full Text] [Related]
17. Epstein-Barr virus-associated B-cell lymphoproliferative disorders and lymphomas: a review.
Marques-Piubelli ML; Salas YI; Pachas C; Becker-Hecker R; Vega F; Miranda RN
Pathology; 2020 Jan; 52(1):40-52. PubMed ID: 31706670
[TBL] [Abstract][Full Text] [Related]
18. EBV-positive B-cell lymphomas and lymphoproliferative disorders: Review from the perspective of immune escape and immunodeficiency.
Satou A; Nakamura S
Cancer Med; 2021 Oct; 10(19):6777-6785. PubMed ID: 34387382
[TBL] [Abstract][Full Text] [Related]
19. [The understanding of Epstein-Barr virus associated lymphoproliferative disorder].
Zhou XG; Zhang YL; Xie JL; Huang YH; Zheng YY; Li WS; Chen H; Liu F; Pan HX; Wei P; Wang Z; Hu YC; Yang KY; Xiao HL; Wu MJ; Yin WH; Mei KY; Chen G; Yan XC; Meng G; Xu G; Li J; Tian SF; Zhu J; Song YQ; Zhang WJ
Zhonghua Bing Li Xue Za Zhi; 2016 Dec; 45(12):817-821. PubMed ID: 28056294
[TBL] [Abstract][Full Text] [Related]
20. Overview of EBV-Associated T/NK-Cell Lymphoproliferative Diseases.
Kimura H; Fujiwara S
Front Pediatr; 2018; 6():417. PubMed ID: 30662890
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]